Literature DB >> 26264832

Multifunctional liposomes having target specificity, temperature-triggered release, and near-infrared fluorescence imaging for tumor-specific chemotherapy.

Kenji Kono1, Munenobu Takashima2, Eiji Yuba2, Atsushi Harada2, Yoshie Hiramatsu3, Hiroyuki Kitagawa3, Takayuki Otani3, Kazuo Maruyama4, Sadahito Aoshima5.   

Abstract

We designed functional liposomes with target specificity, temperature-triggered drug release, and near-infrared fluorescence imaging. We prepared the liposomes by triple functionalization of stable pegylated liposomes with thermosensitive poly[2-(2-ethoxy)ethoxyethyl vinyl ether] chains (lower critical solution temperature around 38 °C) with conjugation of antibody trastuzumab (Herceptin, HER), which targets human epidermal growth factor 2, and with incorporation of indocyanine green for near-infrared fluorescence imaging. The liposomes retained DOX in the interior below physiological temperature but released DOX immediately at temperatures higher than 40 °C. The liposomes exhibited excellent ability for association and internalization to target cells overexpressing Her-2, such as SK-OV3 and SB-BR3 cells, and killed these cells when heated at 45 °C for 5 min. When administered intravenously to mice bearing SK-OV3 tumor, the liposomes having HER accumulated in the tumor more efficiently than the liposomes without HER. They stayed there more than 48 h, as judged with near-infrared fluorescence imaging. Furthermore, when the tumor sites of the mice being administered with the DOX-loaded liposomes were heated mildly at 44°C for 10 min at 7h after administration, tumor growth was suppressed strongly thereafter. Treatment with the HER-conjugated liposomes produced more efficient tumor-suppressive effects. Results demonstrate that the synergy of target-specific association, temperature-triggered drug release, and imaging is important for efficient tumor chemotherapy.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody; Chemotherapy; Doxorubicin; Drug delivery; Liposome; Temperature-sensitive

Mesh:

Substances:

Year:  2015        PMID: 26264832     DOI: 10.1016/j.jconrel.2015.08.005

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  8 in total

1.  In vivo cellular-level real-time pharmacokinetic imaging of free-form and liposomal indocyanine green in liver.

Authors:  Yoonha Hwang; Hwanjun Yoon; Kibaek Choe; Jinhyo Ahn; Jik Han Jung; Ji-Ho Park; Pilhan Kim
Journal:  Biomed Opt Express       Date:  2017-09-26       Impact factor: 3.732

2.  Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications.

Authors:  Parham Sahandi Zangabad; Soroush Mirkiani; Shayan Shahsavari; Behrad Masoudi; Maryam Masroor; Hamid Hamed; Zahra Jafari; Yasamin Davatgaran Taghipour; Hura Hashemi; Mahdi Karimi; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2017-12-12       Impact factor: 7.848

3.  Biocompatible Nanoparticles Based on Amphiphilic Random Polypeptides and Glycopolymers as Drug Delivery Systems.

Authors:  Natalia Zashikhina; Mariia Levit; Anatoliy Dobrodumov; Sergey Gladnev; Antonina Lavrentieva; Tatiana Tennikova; Evgenia Korzhikova-Vlakh
Journal:  Polymers (Basel)       Date:  2022-04-20       Impact factor: 4.967

4.  Site-Specific Labeling of Cyanine and Porphyrin Dye-Stabilized Nanoemulsions with Affibodies for Cellular Targeting.

Authors:  Ahmad Amirshaghaghi; Burcin Altun; Kido Nwe; Lesan Yan; Joel M Stein; Zhiliang Cheng; Andrew Tsourkas
Journal:  J Am Chem Soc       Date:  2018-10-15       Impact factor: 15.419

5.  Superparamagnetic Fe3O4-PEG2K-FA@Ce6 Nanoprobes for in Vivo Dual-mode Imaging and Targeted Photodynamic Therapy.

Authors:  Ting Yin; Peng Huang; Guo Gao; Joseph G Shapter; Yulan Shen; Rongjin Sun; Caixia Yue; Chunlei Zhang; Yanlei Liu; Sui Zhou; Daxiang Cui
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

Review 6.  Current developments in drug delivery with thermosensitive liposomes.

Authors:  Hongshu Bi; Jianxiu Xue; Hong Jiang; Shan Gao; Dongjuan Yang; Yan Fang; Kai Shi
Journal:  Asian J Pharm Sci       Date:  2018-10-31       Impact factor: 6.598

7.  Anti-EphA10 antibody-conjugated pH-sensitive liposomes for specific intracellular delivery of siRNA.

Authors:  Xinlong Zang; Huaiwei Ding; Xiufeng Zhao; Xiaowei Li; Zhouqi Du; Haiyang Hu; Mingxi Qiao; Dawei Chen; Yuihui Deng; Xiuli Zhao
Journal:  Int J Nanomedicine       Date:  2016-08-17

Review 8.  State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy.

Authors:  Elmira Heidarli; Simin Dadashzadeh; Azadeh Haeri
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.